Quale sarebbe il prezzo per General Biologicals Corporation (4117)

Il prezzo per General Biologicals Corporation (4117) è $0.31640033

Qual è la capitalizzazione di mercato per General Biologicals Corporation (4117)

La capitalizzazione di mercato per General Biologicals Corporation (4117) è $22.25M

General Biologicals Corporation (4117) Margine Operativo

General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.

Anno	Margine Operativo	Cambia
Non abbastanza dati per le date fornite.

Anno

Margine Operativo

Cambia

Non abbastanza dati per le date fornite.

Azienda	Margine Operativo	Differenza del margine operativo	Il paese
STERIS plc STE.US	18.91%	-	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	0.00%	-	CN
Ypsomed Holding AG YPSN.SW	0.00%	-	CH
Medacta Group S.A. MOVE.SW	0.00%	-	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	0.00%	-	CN

Azienda

Margine Operativo

Differenza del margine operativo

Il paese